Browsing Tag: SpecialtyPharmaceuticals

Key Highlights:  Implications:   Kashiv’s scaling challenges Biocon/Serum Institute dominance in India’s $15B+ biologics CDMO space (18% CAGR), capturing 10-15% complex...